3M (MMM) has seen a series of significant changes, with varied impacts on shareholder confidence and stock performance. The company has seen a
degree of stock volatility, outpacing industrial sector performance at times, but also experiencing dips in face of broader market gains. Key developments include the
departure of the CFO and the
appointment of a new CEO, William Brown.
Financial performance has exhibited some inconsistency, with adjusted EPS surpassing expectations despite minor sales decline in Q1 2024, and a potential dividend cut.
Operational performance, however, has seen strength. The successful
spin-off of Solventum, and the spin-off of its healthcare business indicates a strategic effort to streamline operations. Q1 earnings report shows robust operations, while full-year 2024 guidance suggests a proactive stance toward improving future profitability. The company, however, remains undervalued, according to intrinsic calculations. Notably, the company's shares remain a favourite among institutional investors, underscoring possible long-term confidence in the MMM's stability and potential growth. Nonetheless, analysts expect a potential decline in earnings, and some foresee a potential 9% downside risk for the stock.
3m Company MMM News Analytics from Tue, 07 Nov 2023 08:00:00 GMT to Sun, 14 Jul 2024 12:36:48 GMT -
Rating -3
- Innovation 3
- Information 6
- Rumor -4
